SCHEMBL30299573

SCHEMBL30299573

c1ccc(CNc2nccc(-c3ccccc3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.55
CLK4 Q9HAZ1 5/20 0.55
CLK1 P49759 4/20 0.55
DYRK1B Q9Y463 3/20 0.55
CLK2 P49760 2/20 0.55
HDAC3 O15379 3/20 0.53
HDAC1 Q13547 3/20 0.53
HDAC2 Q92769 3/20 0.53
HDAC6 Q9UBN7 3/20 0.53
NCOR1 O75376 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
VCP P55072 1/20 0.52
MKNK1 Q9BUB5 2/20 0.52
MAPK13 O15264 2/20 0.51
MAPK12 P53778 2/20 0.51
MAPK11 Q15759 2/20 0.51
MAPK14 Q16539 2/20 0.51
RAF1 P04049 1/20 0.51
MAPK9 P45984 1/20 0.51
PIK3CA P42336 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3651697 0.85 DYRK1A (0.54) DYRK1ACLK4CLK1DYRK1BCLK2
SCHEMBL24334967 0.83 PTGS2 (0.64) DYRK1ACLK4CLK1DYRK1BCLK2
SCHEMBL30299494 0.79 CDK4 (0.54) VCPABL1EGFRPRKCAPRKCD
SCHEMBL11551000 0.79 CDC7 (0.61) CLK4CDC7CYP3A4
SCHEMBL22191614 0.78 DYRK1A (0.54) DYRK1ACLK4CLK1DYRK1BCLK2
SCHEMBL10441707 0.77 ATM (0.55) CDC7LCKCYP3A4
SCHEMBL12597156 0.77 NPSR1 (0.55) CDC7LCK
SCHEMBL22191109 0.77 LCK (0.50) HDAC3HDAC1HDAC2HDAC6CDC7
SCHEMBL18608757 0.77 CDC7 (0.52) CLK4CDC7LCK
SCHEMBL29836535 0.77 ATM (0.55) CDC7LCKCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383863-A1 PREPARATION METHOD FOR PYRIMIDINE-2-AMINE INSTITUTE FOR BASIC SCIENCE (KR) 2024-11-21 US disclosed
WO-2023043292-A1 PREPARATION METHOD FOR PYRIMIDINE-2-AMINE 기초과학연구원 2023-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383863-A1 PREPARATION METHOD FOR PYRIMIDINE-2-AMINE NUDT1, UMPS, DPYD DYRK1A 1573/4885CLK4 1913/4885CLK1 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.